Insider Transactions in Q1 2021 at Keros Therapeutics, Inc. (KROS)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 11
2021
|
Jennifer Lachey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,300
-2.71%
|
$339,200
$64.73 P/Share
|
|
Mar 11
2021
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+7.38%
|
$0
$0.3 P/Share
|
|
Mar 11
2021
|
Claudia Ordonez Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,000
-69.75%
|
$64,000
$64.47 P/Share
|
|
Mar 11
2021
|
Claudia Ordonez Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$0
$0.48 P/Share
|
|
Mar 04
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
11,632
-0.22%
|
$651,392
$56.17 P/Share
|
|
Mar 03
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
12,327
-0.29%
|
$702,639
$57.38 P/Share
|
|
Mar 02
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
10,711
-0.2%
|
$631,949
$59.88 P/Share
|
|
Mar 01
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
12,979
-0.17%
|
$830,656
$64.24 P/Share
|
|
Feb 26
2021
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,200
+35.17%
|
$0
$0.11 P/Share
|
|
Feb 18
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
2,944
-0.05%
|
$182,528
$62.79 P/Share
|
|
Feb 17
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
16,061
-0.29%
|
$963,660
$60.78 P/Share
|
|
Feb 16
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
9,612
-0.21%
|
$567,108
$59.74 P/Share
|
|
Feb 12
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
7,468
-0.13%
|
$463,016
$62.15 P/Share
|
|
Feb 11
2021
|
Jennifer Lachey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,300
-2.82%
|
$344,500
$65.44 P/Share
|
|
Feb 11
2021
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+13.73%
|
$0
$0.3 P/Share
|
|
Feb 11
2021
|
Claudia Ordonez Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,000
-59.35%
|
$65,000
$65.37 P/Share
|
|
Feb 11
2021
|
Claudia Ordonez Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$0
$0.48 P/Share
|
|
Feb 11
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
11,561
-0.17%
|
$751,465
$65.32 P/Share
|